Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies

Nowadays, personalized cancer therapy relies on small molecules, monoclonal antibodies, or antibody–drug conjugates (ADC). Many nanoparticle (NP)-based drug delivery systems are also actively investigated, but their advantage over ADCs has not been demonstrated yet. Here, using the Avidin-Nucleic-Ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Roncato, Francesco, Rruga, Fatlum, Porcù, Elena, Casarin, Elisabetta, Ronca, Roberto, Maccarinelli, Federica, Realdon, Nicola, Basso, Giuseppe, Alon, Ronen, Viola, Giampietro, Morpurgo, Margherita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172284/
https://www.ncbi.nlm.nih.gov/pubmed/30287819
http://dx.doi.org/10.1038/s41467-018-06602-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172284/
https://www.ncbi.nlm.nih.gov/pubmed/30287819
http://dx.doi.org/10.1038/s41467-018-06602-6

Ejemplares similares